Alterations in insulin-like growth factor binding protein-3 proteolysis and complex formation in the arthritic joint

Journal of Endocrinology

Volumn 165, Issue 3, 2000, Pages 545-556

  Whellams, E J ^a   Maile, L A ^a   Fernihough, J K ^a   Billingham, M E J ^a   Holly, J M P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ARTHRITIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; JOINT; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

EID: 0034124119     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650545     Document Type: Article

References (56)

1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al. 1986 Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis and Rheumatism 29 1039-1049.
2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31 315-324.
3. Bang P & Fielder PJ 1997 Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3. Endocrinology 138 3912-3917.
4. Baxter RC & Martin JL 1989a Binding proteins for the insulin-like growth factors - structure, regulation and function. Progress in Growth Factor Research 1 49-68.
5. Baxter RC & Martin JL 1989b Structure of the Mr 140 000 growth hormone-dependent insulin-like growth factor binding proteincomplex: determination by reconstitution and affinity labelling. PAMS 86 6898-6902.
6. Booth BA, Boes M & Bar RS 1996 IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments. American Journal of Physiology 271 E465-E470.
7. Bowsher RR, Lee W-H, Apathy JM, O'Brien PJ, Ferguson AL & Henry DP 1991 Measurement of insulin-like growth factor-II in physiological fluids and tissues. An improved extraction procedure and radioimmunoassay for lumen and rat fluids. Endocrinology 128 805-814.
8. Campbell PG, Durham SK, Suwanichkul A, Hayes JD & Powell DR 1998 Plasminogen binds the heparin-binding domain of insulin-like growth factor binding protein-3. American Journal of Physiology 275 E321-E331.
9. Cheetham TD, Taylor A, Holly JMP, Clayton K, Cwyfan-Hughes SC & Dunger DB 1994 The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF binding proteins in adolescents with insulin-dependent diabetes mellitus. Journal of Endocrinology 142 367-374.
10. Claussen M, Kubler B, Wendland M, Neifer K, Schmidt B. Zapf J & Braulke T 1997 Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 138 3797-3803.
11. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS & Woessner JF Jr 1989 Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. Journal of Clinical Investigation 84 678-685.
12. De Keyser F, Elewaut D, Vermeersch J, De Wever N, Cuvelier C & Veys EM 1995 The role of T cells in rheumatoid arthritis. Clinical Rheumatology 14 (suppl 2) 5-9.
13. Dequeker J, Mohan R, Finkelman RD, Aerssens J & Baylink DJ 1993 Generalised osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increase bone density and protection against osteoporosis. Arthritis and Rheumatism 36 1702-1708.
14. Dore S, Pelletier JP, DiBattista JA, Tardif G, Brazeau P & Martel-Pelletier J 1994 Human osteoarthntic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Arthritis and Rheumatism 37 253-263.
15. Dore S, Abribat T, Rousseau N, Brazeau P, Tardif G, DiBattista JA, Cloutier JM, Pelletier JP & Martel-Pelletier J 1995 Increased insulin-like growth factor-I production by human osteoarthritic chondrocytes is not dependent on growth hormone action. Arthritis and Rheumatism 38 413-419.
16. Durham SK, Suwanichkul A, Hayes JD, Herington AC, Powell DR & Campbell PG 1999 The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis. Hormone and Metabolic Research 31 216-225.
17. Fassbender HG 1994 Inflammatory reactions in arthritis. In The Handbook of Immunopharmacology: Immunopharmacology of Joints and Connective Tissue, pp 84-96. Eds ME Davies & JT Dingle. London: Academic Press.
18. Fernihough JK, Billingham MEJ, Cwyfan-Hughes S & Holly JMP 1996 Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis and Rheumatism 39 1556-1565.
19. Fowlkes JL, Suzuki K, Nagase H & Thrailkill KM 1994 Proteolysis of insulin-like growth factor-binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. Endocrinology 135 2810-2813.
20. Hardingham TE, Bayliss MT, Rayan V & Noble DP 1992 Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. British Journal of Rheumatology 31 (suppl 1) 1-6.
21. Harris ED 1990 Rheumatoid arthritis. Pathophysiology and implications for therapy. New England Journal of Medicine 322 1277-1289.
22. Helle SI, Ankler GB, Meadows KA, Holly JMP & Lonning PE 1998 Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Maturitas 28 259-265.
23. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M & Binoux M 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. Journal of Clinical Endocrinology ana Metabolism 71 797-805.
24. Howell DS & Pelletier JP 1993 Etiopathogenesis of OA. In Arthritis and Allied Conditions, edn 12, pp 21-29. Eds DJ McCarty & WJ Koopman. Philadelphia: Lea and Febiger.
25. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
26. Keyszer GM, Heer AH, Kriegsmann J, Geiler T, Keysser C, Gay RE & Gay S 1995 Detection of insulin-like growth factor-I and II (IGF-I,II) in synovial tissue specimens of patients with rheumatoid arthritis and osteoarthritis by in situ hybridisation. Journal of Rheumatology 22 375-381.
27. Kubler B, Cowell S, Zapf J & Braulke T 1998 Proteolysis of insulin-like growth factor binding proteins by a novel 50 kilodalton metalloproteinase in human pregnancy serum. Endocrinology 139 1556-1563.
28. Kusada J, Otsuka T, Matsui N, Hirano T, Asai K & Kato T 1993 Immuno-reactive human epidermal growth factor (h-EGF) in rheumatoid synovial fluids. Journal of the Japanese Orthopaedic Association 67 859-865.
29. Lamson G, Giudice LC & Rosenfeld RG 1991 A simple assay for proteolysis of IGFBP-3. Journal of Clinical Endocrinology and Metabolism 72 1391-1393.
30. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR & Conover CA 1999 The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. PNAS 96 3149-3153.
31. Lefebvre I, Peeters-Joris C & Vaes G 1990 Modulation by interleukin-1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochimica et Biophysica Acta 1052 366-378.
32. MacNaul KL, Chartrain N, Lark M, Tocci MJ & Hutchinson NI 1990 Discoordinate expression of stromelysm, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Journal of Biological Chemistry 265 17238-17245.
33. McQuillan DJ, Handley CJ & Robinson HC 1986a Control of proteoglycan biosynthesis. Biochemical Journal 237 741-747.
34. McQuillan DJ, Handley CJ, Campbell MA, Bolis S, Milway VE & Herington AC 1986b Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-1 in cultured bovine articular cartilage. Biochemical Journal 240 423-430.
35. Maile LA, Xu S, Cwyfan-Hughes SC, Fernihough JK, Pell JM & Holly JMP 1998 Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial and synovial fluid. Endocrinology 139 4772-4781.
36. Matsumoto T, Tsukazaki T, Enomoto H, Iwasaki K & Yamashita S 1994 Effects of interleukin-1 beta on insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Annals of the Rheumatic Diseases 53 128-133.
37. Matsumoto T, Gargosky SE, Iwasaki K & Rosenfeld RG 1996 Identification and characterisation of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. Journal of Clinical Endocrinology and Metabolism 81 150-155.
38. Morales TI & Hascall VC 1989 Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis and Rheumatism 32 1197-1201.
39. Mort JS, Dodge GR, Roughley PJ, Liu J, Finch SJ, DiPasquale G & Poole AR 1993 Direct evidence for active metalloproteinases mediating matrix degradation in interleukin-1 stimulated human articular cartilage. Matrix 13 95-102.
40. Mow VC, Ratcliffe A & Poole AR 1992 Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials 13 67-97.
41. Neidel J, Blum WF, Schaeffer HJ, Schulze M, Schonau E, Lindschau J & Foll J 1997 Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis. Rheumatology International 17 29-37.
42. Pelletier JP, DiBattista JA, Roughley P, McCollum R & Martel-Pelletier J 1993 Cytokines and inflammation in cartilage degradation. Rheumatic Disease Clinics of North America 19 545-568.
43. Roitt I, Brostoff J & Male D 1989 The complement system. In Immunology, edn 2, pp 164-170. London: Gower Medical Publishing.
44. Schalkwijk J, Joosten LAB, van den Berg WB, van Wyk JJ & van de Putte LBA 1989 Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid. Arthritis and Rheumatism 32 66-70.
45. Schneiderman R, Snir E, Popper O, Hiss J, Stein H & Maroudas A 1995 Insulin-like growth factor-I and its complexes in normal human articular cartilage: studies of partition and diffusion. Archives of Biochemistry and Biophysics 324 159-172.
46. Stevens CR, Blake DR, Merry P, Revell PA & Levick JR 1991 A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis and Rheumatism 34 1508-1513.
47. Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, Lin SJ, Rayan G & Koch AE 1995 Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease. Clinical Immunology and Immunopathology 76 187-194.
48. Tavera C, Abribat T, Reboul P, Dore S, Brazeau P, Pelletier JP & Pelletier JM 1996 IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis and Cartilage 4 263-274.
49. Trippel SB 1995 Growth factor actions on articular cartilage. Journal of Rheumatology 22 (suppl 43) 129-132.
50. Tyler JA 1989 Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochemical Journal 260 543-548.
51. Van de Loo AAJ, Joosten LAB, Van Lent PLEM, Arntz OJ & Van den Berg WB 1995 Role of interleukin-1, tumor necrosis factor-α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in vivo blocking in murine antigen-and zymosan-induced arthritis. Arthritis and Rheumatism 38 164-172.
52. Verschure PJ, van Noorden CJF, van Marle J & van den Berg WB 1996 Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes. Histochemical Journal 28 835-857.
53. Vetter U, Zapf J, Heit W, Helbing G, Heinze E, Froesch ER & Teller WM 1986 Human fetal and adult chondrocytes: effect of insulin-like growth factors I and II, insulin, and growth hormone on clonal growth. Journal of Clinical Investigation 77 1903-1908.
54. Virca GD, Mallya RK, Pepys MB & Schnebli HP 1984 Quantitation of human leukocyte elastase, cathepsin G, α-2 macroglobulin and α-1 proteinase inhibitor in osteoarthritis and rheumatoid arthritis synovial fluids. Advances in Experimental Medicine and Biology 167 345-353.
55. Willis DH Jr & Liberti JP 1985 Post-receptor actions of somatomedin on chondrocyte collagen biosynthesis. Biochimica et Biophysica Acta 844 72-80.
56. Yateman ME, Claffey DC, Cwyfan-Hughes SC, Frost VJ, Wass JA & Holly JM 1993 Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-1 (IGF-I) by altering endogenous IGF-binding protein production. Journal of Endocrinology 137 151-159.